Diabetes Mellitus Type 2, Insulin Resistance
Conditions
Keywords
Diabetes mellitus Type 2, Telemedicine, Insulin
Brief summary
The purpose of the study is to show if telemonitoring and automated feedback regarding glucose management, physical activity, blood pressure, and body weight improves treatment of patients with insulin dependent Type 2 Diabetes mellitus.
Detailed description
In this clinical trial 50 patients with insulin dependent type 2 diabetes will be randomised in two study arms: monitoring of blood glucose and blood pressure using a telemedical device or in an arm with treatment as usual. Patients will the following measurement devices: blood glucose, blood pressure. Both devices can communicate with a mobile phone, which will also be provided to the patients. The mobile phone will transfer the data to a central, safe server. Patients will receive automated reminder/feedback. Caregivers can evaluate the transferred data whenever necessary via a web-based access. Data will be presented in tables as well as trend figures.
Interventions
DEVICETelemedical device
Monitoring of blood glucose,insulin dose, blood pressure, lifestyle factors with the telemedical device. Monitoring of system availability, percentage of data transfer, acceptance.
Sponsors
National Bank of Austria
Medical University of Vienna
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Diabetes mellitus Type 2, age 18-70 years, able to use a mobile phone
Exclusion criteria
* Pacemaker, intracardial defibrillator, no cure planned within the active study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| System availability, acceptance, transmission rate | 3 months |
Secondary
| Measure | Time frame |
|---|---|
| HbA1c | 3 months |
Countries
Austria
Contacts
Primary ContactKarin Schindler, PhD
Backup ContactBernhard Ludvik, MD
Outcome results
None listed